Qulipta is a medicine that helps prevent migraines in adults. It is a pill taken by mouth every day, not just when a migraine starts. It works by blocking a protein in the body called CGRP that helps set off migraine attacks.
Every report comes from a Lived member, sent anonymously.
Have you tried Qulipta (Atogepant) for Migraines?
Atogepant, sold as Qulipta, is a prescription tablet taken every day to prevent migraine attacks in adults. It is approved both for episodic migraine and for chronic migraine, the more frequent form. In the studies behind its approval, people with episodic migraine averaged about 8 migraine days a month before treatment, and people with chronic migraine about 19. It is a preventive medicine: its job is to make attacks less frequent, not to stop one that has already started. An attack that breaks through still needs its own treatment plan. Atogepant belongs to a newer group of migraine medicines called gepants, which act on a signaling molecule called calcitonin gene-related peptide (CGRP). The American Headache Society considers CGRP-targeting treatments, which include atogepant and several antibody medicines, a first-line option for prevention. That means a person does not have to try and fail older preventive medicines first.
CGRP is a signaling molecule used by nerves in and around the head. Research has shown that it plays a key role in how migraine attacks develop. Atogepant blocks the CGRP receptor, the docking site the molecule needs in order to pass on its signal. Taken daily, it keeps that pathway damped down, and attacks tend to come less often. It is not a pain reliever, which is why it is taken on good days as well as bad ones.
Qulipta comes as 10 mg, 30 mg and 60 mg tablets taken once a day, with or without food. For episodic migraine, the prescriber chooses one of the three strengths. For chronic migraine, the dose is 60 mg. Taking it at about the same time each day makes it easier to remember. A lower dose, or a different medicine, may be needed for people who take certain other medicines (described under Interactions & Warnings). With severe kidney disease or dialysis, the dose for episodic migraine is 10 mg, and atogepant is not recommended for chronic migraine. It should be avoided in severe liver disease. If a dose is missed, take it when remembered unless the next one is nearly due, and do not take two doses together. Keep taking it on headache-free days, and talk with the prescriber before stopping.
Nausea, constipation and tiredness or sleepiness are the most common side effects, and they were more frequent at the 60 mg dose. In the trials, about 9 in 100 people on 60 mg had nausea, compared with 3 in 100 on a placebo (dummy pill). Some people notice a lower appetite, dizziness or some weight loss. Very few people in the trials stopped the medicine because of side effects. Serious allergic reactions are uncommon but have happened, sometimes days after a dose rather than right away. Any sign of an allergic reaction, such as hives, rash, itching or swelling of the face, means stopping the tablet and getting medical attention right away. Trouble breathing is an emergency that needs immediate emergency care.
Several medicines change how much atogepant stays in the body. The antifungal itraconazole and similar strong blockers of a liver enzyme that processes it raise atogepant levels, so the dose is cut to 10 mg. The antibiotic rifampin and other drugs that speed up that enzyme, including the herbal supplement St. John's wort, can lower levels and make it less effective; for chronic migraine, the stronger of these combinations are not recommended. Topiramate, an older migraine preventive, also lowers levels somewhat, which matters if the two are used together. Tell the prescriber and pharmacist about every prescription, over-the-counter medicine and supplement, and ask about grapefruit and grapefruit juice. Atogepant can cause new high blood pressure or make existing high blood pressure worse. It was reported most often within the first week, and some people needed blood pressure treatment or hospital care. Report higher-than-usual readings to the prescriber, especially if you already have high blood pressure. It can also bring on or worsen Raynaud's phenomenon, in which blood flow to the fingers or toes drops, often with cold or stress. The fingers or toes may turn white, blue or red and feel cold, numb or tingly. With gepants, this usually began within a couple of days of a dose. If it happens, stop the tablet and contact the prescriber right away; it usually clears after stopping. People who already have Raynaud's should discuss this risk before starting. There is not enough information on atogepant in pregnancy, and animal studies showed effects on growth of the young at exposures above those used in people. Anyone pregnant or planning a pregnancy should talk with the prescriber; a pregnancy registry tracks outcomes. Small amounts pass into breast milk, and effects on a nursing baby are not known. People who have had an allergic reaction to atogepant should not take it.
Atogepant is judged over weeks to months, by counting migraine days rather than by how one attack feels. In 12-week trials in episodic migraine, migraine days fell by about 4 a month on atogepant, compared with about 2.5 on placebo, and roughly 6 in 10 people cut their migraine days at least in half (versus 3 in 10 on placebo). In chronic migraine, migraine days fell by about 7 a month versus 5 on placebo, and about 4 in 10 halved them (versus about 1 in 4). Days needing acute migraine medicine fell as well. For most people it means fewer attacks, not none, and some people notice little change. A headache diary that records migraine days and acute medicine use gives the clearest picture of whether it is working. Follow-up visits review the diary, side effects and blood pressure. When it helps, it is taken continuously, and how long to continue is worth revisiting with the prescriber over time. If it does not help enough, the dose can be adjusted or a different preventive tried.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Qulipta (Atogepant), what you've noticed, or ask the community a question.